P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy

Autor: Fernández-Aroca, D.M., Roche, O., Sabater, S., Pascual-Serra, R., Ortega-Muelas, M., Sánchez Pérez, I., Belandia, B., Ruiz-Hidalgo, M.J., Sánchez-Prieto, R.
Zdroj: In Cancer Letters 1 June 2019 451:23-33
Databáze: ScienceDirect